Proficio Capital Partners’s Novavax NVAX Stock Holding History

Proficio Capital Partners’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3	Closed	–	–	1127
2016 Q2	$0	Buy	+3	New	+$344	﹤0.01%	1124

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Proficio Capital Partners's NVAX Position: Q3 2016 in Review

Proficio Capital Partners sold out of Novavax (NVAX) in Q3 2016, closing a stake of 3 shares.

Proficio Capital Partners first reported a position in NVAX in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 165 funds tracked by Wall St. Rank hold NVAX as of Q3 2016.

Proficio Capital Partners reported no remaining Novavax position as of Q3 2016 after selling out during the quarter.
Proficio Capital Partners sold 3 Novavax shares in Q3 2016.
Proficio Capital Partners first reported a position in Novavax in Q2 2016 and held it in 1 quarter.
Proficio Capital Partners's Novavax position peaked at $0 in Q2 2016.
165 funds tracked by Wall St. Rank held Novavax as of Q3 2016.

Based on Proficio Capital Partners's 13F filing for Q3 2016, filed 25 Oct 2016.